National and Kapodistrian University of Athens
Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους
Abstract
dc:descriptionThe purpose of this study is to describe with great accuracy the pharmacokinetics of Avastin, in the left eye and serum, after intravitreal injection of 1.25 mg/0.05 ml Avastin in the right eye in rabbits. Avastin is a very important drug in Ophthalmology today. The right eye of 20 rabbits was injected intravitreally with 1.25 mg/0.05 ml Avastin at day 0. Both eyes of four rabbits each time were enucleated at days 1, 3, 8, 15 and 29. Bevacizumab concentrations were measured in vitreous and aqueous of the left eye as well as the serum. The concentration of anti-bevacizumab antibodies was also measured in serum using high sensitivity ELISA. Maximum vitreous (0.335 ng/mL) and aqueous humor (1.61 ng/mL) concentrations of bevacizumab in the left eye were measured at day 8. The same day was measured the maximum concentration of bevacizumab in serum (0.413 μg/mL). A concentration of 0.218 ng/mL was maintained in the vitreous 29 days after injection. A concentration of 0.11 ng/mL was maintained in aqueous humor 29 days after injection. In serum, a concentration of 0.032 μg/mL was maintened 29 days after intravitreal injection of 1.25 mg/0.05 ml Avastin in the right eye. Half-life values of bevacizumab in the left aqueous humor and serum were 5.56 and 5.87 days, respectively.The concentration of anti-bevacizumab antibodies in serum is at least 200-fold lower than the bevacizumab concentration. Therefore, anti-bevacizumab antibodies cannot have an important effect on bevacizumab concentration because of their low concentration.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sinapis, Aggelos
- Σινάπης, Άγγελος
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/31659